Evaluation of perfusion CT and dual-energy CT for predicting microvascular invasion of hepatocellular carcinoma
- 13 April 2022
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (6) , 2115-2127
Abstract
Purpose Evaluation of perfusion CT and dual-energy CT (DECT) quantitative parameters for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC) prior to surgery. Methods This prospective single-center study included fifty-six patients (44 men; median age 67; range 31–84) who provided written informed consent. Inclusion criteria were (1) treatment-naïve patients with a diagnosis of HCC, (2) an indication for hepatic resection, and (3) available arterial DECT phase and perfusion CT (GE revolution HD-GSI). Iodine concentrations (IC), arterial density (AD), and 9 quantitative perfusion parameters for HCC were correlated to pathological results. Radiological parameters based principal component analysis (PCA), corroborated by unsupervised heatmap classification, was meant to deliver a model for predicting MVI in HCC. Survival analysis was performed using univariable log-rank test and multivariable Cox model, both censored at time of relapse. Results 58 HCC lesions were analyzed (median size 42.3 mm; range of 20–140). PCA showed that the radiological model was predictive of tumor grade (p = 0.01), intratumoral MVI (p = 0.004), peritumoral MVI (p = 0.04), MTM (macrotrabecular-massive) subtype (p = 0.02), and capsular invasion (p = 0.02) in HCC. Heatmap classification of HCC showed tumor heterogeneity, stratified into three main clusters according to the risk of relapse. Survival analysis confirmed that permeability surface-area product (PS) was the only significant independent parameter, among all quantitative tumoral CT parameters, for predicting a risk of relapse (Cox p value = 0.004). Conclusion A perfusion CT and DECT-based quantitative imaging profile can provide a diagnosis of histological MVI in HCC. PS is an independent parameter for relapse. Clinical trials ClinicalTrials.gov: NCT03754192.Keywords
This publication has 42 references indexed in Scilit:
- Oncologic Applications of Dual-Energy CT in the AbdomenRadioGraphics, 2014
- Quantitative therapy response assessment by volumetric iodine-uptake measurement: Initial experience in patients with advanced hepatocellular carcinoma treated with sorafenibEuropean Journal of Radiology, 2013
- CT Perfusion in Oncologic Imaging: A Useful Tool?American Journal of Roentgenology, 2013
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Liver Fibrosis in Chronic Hepatitis C Virus Infection: Differentiating Minimal from Intermediate Fibrosis with Perfusion CTRadiology, 2010
- Early Antiangiogenic Activity of Bevacizumab Evaluated by Computed Tomography Perfusion Scan in Patients with Advanced Hepatocellular CarcinomaThe Oncologist, 2008
- Advanced Hepatocellular Carcinoma: CT Perfusion of Liver and Tumor Tissue—Initial Experience1Radiology, 2007
- Decoding global gene expression programs in liver cancer by noninvasive imagingNature Biotechnology, 2007
- Quantitative Tumor Perfusion Assessment with Multidetector CT: Are Measurements from Two Commercial Software Packages Interchangeable?Radiology, 2007
- Hepatic Perfusion Parameters in Chronic Liver DiseaseAmerican Journal of Roentgenology, 2001